CGTX vs KMX · $120.8M cap vs P/E 19, rev $25.88B
Cognition Therapeutics Inc (CGTX) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
CGTX does not have a complete income-statement cache yet.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
CGTX currently screens at market cap $120.8M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the CGTX and KMX stock pages for the full models.
Not investment advice.